• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血管手术期间的抗凝监测:Hemochron低范围活化凝血时间(ACT-LR)的准确性

Anticoagulation monitoring during vascular surgery: accuracy of the Hemochron low range activated clotting time (ACT-LR).

作者信息

Tremey B, Szekely B, Schlumberger S, François D, Liu N, Sievert K, Fischler M

机构信息

Department of Anaesthesiology, Hôpital Foch, Suresnes, France.

出版信息

Br J Anaesth. 2006 Oct;97(4):453-9. doi: 10.1093/bja/ael194. Epub 2006 Jul 27.

DOI:10.1093/bja/ael194
PMID:16873382
Abstract

BACKGROUND

Activated clotting time (ACT) is currently used to monitor high concentrations of heparin anticoagulation. A new instrument, the Hemochron Jr Signature device, has been specifically designed to measure ACT in low-range heparin plasma concentrations (ACT-LR). The purpose of this study was to compare ACT-LR with anti-Xa activity in patients receiving low-dose i.v. heparin during vascular surgery.

METHODS

Thirty patients, undergoing arterial vascular surgery, were included in the study and received unfractionated heparin (initial dose 50 u kg(-1)). One hundred and thirty-two pairs of blood samples were simultaneously collected during surgery to determine ACT-LR and anti-Xa activity. Pearson correlation, Kappa test, ROC curve and a specific clinical interpretation of the correlation were performed.

RESULTS

ACT-LR ranged from 68 to 380 s, anti-Xa activity from 0 to 1.45 u ml(-1). We observed a strong correlation between anti-Xa activity and ACT-LR (r(2)=0.87; P<0.0001). Accuracy of ACT-LR was good for anti-Xa activity up to 0.6 u ml(-1) (Kappa, 0.94; accuracy, 97%) and 0.8 u ml(-1) (Kappa, 0.79; accuracy, 90%), and poor for anti-Xa activity above 1 u ml(-1) (Kappa, 0.59). A clinical interpretation of the correlation graph found 98% of measured ACT-LR values to be accurate.

CONCLUSION

Hemochron Jr Signature provides measurements of ACT-LR, which are accurate for monitoring heparin anticoagulation at anti-Xa activity below 0.8 u ml(-1).

摘要

背景

活化凝血时间(ACT)目前用于监测高浓度肝素抗凝。一种新仪器,即Hemochron Jr Signature设备,专门设计用于测量低范围肝素血浆浓度下的ACT(ACT-LR)。本研究的目的是比较接受血管手术期间低剂量静脉注射肝素患者的ACT-LR与抗Xa活性。

方法

30例接受动脉血管手术的患者纳入本研究,并接受普通肝素(初始剂量50 U kg⁻¹)。手术期间同时采集132对血样以测定ACT-LR和抗Xa活性。进行了Pearson相关性分析、Kappa检验、ROC曲线分析以及相关性的具体临床解读。

结果

ACT-LR范围为68至380秒,抗Xa活性范围为0至1.45 U ml⁻¹。我们观察到抗Xa活性与ACT-LR之间存在强相关性(r² = 0.87;P < 0.0001)。ACT-LR对于抗Xa活性高达0.6 U ml⁻¹时准确性良好(Kappa值为0.94;准确性为97%),对于抗Xa活性为0.8 U ml⁻¹时也良好(Kappa值为0.79;准确性为90%),而对于抗Xa活性高于1 U ml⁻¹时准确性较差(Kappa值为0.59)。相关性图的临床解读发现98%的测量ACT-LR值是准确的。

结论

Hemochron Jr Signature可提供ACT-LR测量值,在抗Xa活性低于0.8 U ml⁻¹时,对于监测肝素抗凝是准确的。

相似文献

1
Anticoagulation monitoring during vascular surgery: accuracy of the Hemochron low range activated clotting time (ACT-LR).血管手术期间的抗凝监测:Hemochron低范围活化凝血时间(ACT-LR)的准确性
Br J Anaesth. 2006 Oct;97(4):453-9. doi: 10.1093/bja/ael194. Epub 2006 Jul 27.
2
Comparison of activated clotting times obtained using Hemochron and Medtronic analysers in patients receiving anti-thrombin therapy during cardiac catheterisation.在心脏导管插入术期间接受抗凝血酶治疗的患者中,使用Hemochron分析仪和美敦力分析仪获得的活化凝血时间的比较。
Thromb Haemost. 2009 Mar;101(3):535-40.
3
Validation of a bedside activated clotting time test (Hemochron Jr II Signature) with low dose heparin therapy.低剂量肝素治疗床边活化凝血时间检测(Hemochron Jr II Signature)的验证
Anaesthesia. 2009 Apr;64(4):430-4. doi: 10.1111/j.1365-2044.2008.05822.x.
4
Comparison between activated clotting time and anti-activated factor X activity for the monitoring of unfractionated heparin therapy in patients with aortic aneurysm undergoing an endovascular procedure.比较活化凝血时间和抗活化因子 X 活性在血管内手术治疗腹主动脉瘤患者中监测未分级肝素治疗的效果。
J Vasc Surg. 2018 Aug;68(2):400-407. doi: 10.1016/j.jvs.2017.11.079. Epub 2018 Mar 20.
5
Assessment of Heparin Anticoagulation Measured Using i-STAT and Hemochron Activated Clotting Time.使用i-STAT和Hemochron活化凝血时间对肝素抗凝作用的评估。
J Cardiothorac Vasc Anesth. 2018 Aug;32(4):1603-1608. doi: 10.1053/j.jvca.2018.01.027. Epub 2018 Jan 31.
6
Point-of-care measurement of activated clotting time for cardiac surgery as measured by the Hemochron signature elite and the Abbott i-STAT: agreement, concordance, and clinical reliability.心脏手术中即时凝血时间的床边测量:Hemochron signature elite 和 Abbott i-STAT 的比较:一致性、符合率和临床可靠性。
BMC Anesthesiol. 2019 Sep 6;19(1):174. doi: 10.1186/s12871-019-0846-z.
7
In vivo and in vitro evaluation of the heparin management test versus the activated coagulation time for monitoring anticoagulation level in aprotinin-treated patients during cardiac surgery.在心脏手术期间,对抑肽酶治疗患者监测抗凝水平时,肝素管理试验与活化凝血时间的体内和体外评估。
Heart Surg Forum. 2004;7(6):E599-604. doi: 10.1532/HSF98.20041134.
8
Monitoring activated clotting time for combined heparin and aprotinin application: in vivo evaluation of a new aprotinin-insensitive test using Sonoclot.监测肝素与抑肽酶联合应用时的活化凝血时间:使用Sonoclot对一种新型抑肽酶不敏感检测方法的体内评估
Eur J Cardiothorac Surg. 2006 Aug;30(2):278-84. doi: 10.1016/j.ejcts.2006.05.016. Epub 2006 Jul 7.
9
Anticoagulation Monitoring Under ECMO Support: A Comparative Study Between the Activated Coagulation Time and the Anti-Xa Activity Assay.ECMO 支持下的抗凝监测:激活凝血时间与抗 Xa 活性测定的比较研究。
J Intensive Care Med. 2020 Jul;35(7):679-686. doi: 10.1177/0885066618776937. Epub 2018 May 16.
10
Intraoperative Monitoring of Heparin: Comparison of Activated Coagulation Time and Whole Blood Heparin Measurements by Different Point-of-Care Devices with Heparin Concentration by Laboratory-Performed Plasma Anti-Xa Assay.肝素的术中监测:不同床旁检测设备的活化凝血时间和全血肝素测量值与实验室血浆抗Xa活性测定的肝素浓度的比较。
Lab Med. 2019 Oct 10;50(4):348-356. doi: 10.1093/labmed/lmz014.

引用本文的文献

1
Rats subject to extracorporeal membrane oxygenation have improved cardiac function following anticoagulation and reversal with factor IXa aptamer-antidote oligonucleotide pair.接受体外膜肺氧合的大鼠在使用因子IXa适配体-解毒剂寡核苷酸对进行抗凝和抗凝逆转后,心脏功能得到改善。
Cardiol Plus. 2025 Apr-Jun;10(2):87-98. doi: 10.1097/CP9.0000000000000122. Epub 2025 Jun 24.
2
Thromboelastometry and two activated clotting tests in detecting residual heparin after protamine in cardiac surgical patients: A prospective cohort study.血栓弹力图和两项活化凝血试验在检测心脏手术患者使用鱼精蛋白后残留肝素中的应用:一项前瞻性队列研究。
Eur J Anaesthesiol. 2025 May 1;42(5):398-406. doi: 10.1097/EJA.0000000000002122. Epub 2025 Feb 10.
3
Laboratory Assessment of Unfractionated Heparin (UFH) with Activated Clotting Time (ACT) and Anti-Xa Activity during Peripheral Arterial Angiographic Procedure.
外周动脉血管造影术中采用活化凝血时间(ACT)和抗Xa活性对普通肝素(UFH)进行实验室评估。
Diagnostics (Basel). 2023 Apr 20;13(8):1489. doi: 10.3390/diagnostics13081489.
4
Anaesthesia for endovascular repair of ruptured abdominal aortic aneurysms.破裂性腹主动脉瘤血管内修复术的麻醉
BJA Educ. 2022 Jun;22(6):208-215. doi: 10.1016/j.bjae.2022.02.001. Epub 2022 Mar 11.
5
Periprocedural management of anticoagulation for atrial fibrillation catheter ablation in direct oral anticoagulant-treated patients.直接口服抗凝剂治疗患者房颤导管消融围手术期的抗凝管理
Clin Cardiol. 2018 May;41(5):646-651. doi: 10.1002/clc.22944. Epub 2018 May 10.
6
[Portable coagulometer devices in the monitoring and control of oral anticoagulation therapy: a systematic review].[便携式凝血计设备在口服抗凝治疗监测与控制中的应用:一项系统评价]
Aten Primaria. 2011 Mar;43(3):148-56. doi: 10.1016/j.aprim.2010.03.017. Epub 2010 Oct 30.
7
Monitoring unfractionated heparin in pediatric patients with congenital heart disease having cardiac catheterization or cardiac surgery.监测行心导管检查或心脏手术的先天性心脏病儿科患者的未分级肝素。
J Thromb Thrombolysis. 2010 May;29(4):429-36. doi: 10.1007/s11239-009-0391-6.